Navigation Links
Higher Education Foundation in Brazil Seals Its Continued Relationship with Thomson Reuters for Academic Healthcare Content
Date:11/9/2010

BRASILIA, Brazil, Nov. 9, 2010 /PRNewswire/ -- The Coordination for the Improvement of Personnel in Higher Education (CAPES) today hosts an official signing ceremony, celebrating the 10th anniversary of Portal de Periodicos. CAPES will sign contract renewals with Thomson Reuters and other international publishers who are part of the Portal.

Thomson Reuters is pleased to provide CAPES with access to its Micromedex® solutions, which include evidence-based information on drugs and drug interactions, disease management, toxicology, alternative medicine, and intravenous drug compatibility. By tapping into this integrated reference source, CAPES ensures that Brazil's students are kept up-to-date with the world's best clinical evidence.

It is important for CAPES to provide Brazil's scholarly community access to the world's leading publishers. Medical and pharmacy students, clinical researchers and other members of national academic programs, through Thomson Reuters, can tap into the world's best clinical evidence on drugs and disease.

Affiliated to the Ministry of Education, CAPES is responsible for the Brazilian post graduate academic system. It works as an agency to support, evaluate, regulate and set rules that guide academic programs with the aim of achieving standards of excellence.

The Portal de Periodicos was created in November 2000 to deliver online access to current scientific content in order to reduce regional differences in the Brazilian research and post graduate system.  It provides more than 268 institutions with access to more than 15,000 journals.

About CAPES

CAPES is a Foundation within the Ministry of Education in Brazil whose central purpose is to coordinate efforts to improve the quality of Brazil's faculty and staff in higher education through grant programs. CAPES is particularly concerned with the training of Doctoral candidates, Pre-doctoral short-term researchers, and Post-doctoral Scholars.

About Thomson Reuters

Thomson Reuters is the world's leading source of intelligent information for businesses and professionals.  We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial, legal, tax and accounting, healthcare and science and media markets, powered by the world's most trusted news organization.  With headquarters in New York and major operations in London and Eagan, Minnesota, Thomson Reuters employs 55,000 people and operates in over 100 countries.  For more information, go to www.thomsonreuters.com.


'/>"/>
SOURCE Thomson Reuters
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. BSGI Posts Higher Sensitivity than Mammography or MRI for the Detection of Ductal Carcinoma In Situ
2. Preclinical Studies Show Potential Progress Toward Identifying Specific Tumor Types With Higher Likelihood of Demonstrating Response to Anti-Cancer Compounds Early in Clinical Development
3. Obesity-Related Hormone is Higher in Children with Down Syndrome
4. Pharmion Submits European Marketing Authorization Application (MAA) for Vidaza(R) in Patients with Higher-Risk Myelodysplastic Syndromes (MDS)
5. Pegintron(TM) Plus Weight-Based Rebetol(R) Resulted in Higher SVR Than Flat Dosing; Low Relapse Rates in Patients With Chronic Hepatitis C
6. TAP Pharmaceutical Products Inc. Announces Phase 3 TAK-390MR Data Demonstrating Higher Overall Healing Versus Lansoprazole in Patients with Erosive Esophagitis
7. Pressure Cycling Technology (PCT) Results in a Higher Yield of Proteins and in the Extraction of Proteins Not Previously Identified in Cancer, Stroke, and IVF Studies
8. Takedas Investigational PPI TAK-390MR Demonstrated Higher Healing Rates Compared to Lansoprazole as the Severity of Erosive Esophagitis Grade Increased, a New Integrated Analysis Showed
9. New Study Shows that PEGASYS(R) Regimen Provides Higher Sustained Virological Response Rates for Hepatitis C Patients
10. A First-Line Therapy for Renal Cell Carcinoma that can Increase Overall Survival when Compared with Sutent Would Earn a Higher Patient Share in the United States Than in Europe
11. Study Finds Family History, Higher Incidence of Sunburns Associated With Rosacea
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... April 28, 2016  While Abbott,s announced purchase ... company,s valve repair and stent business, healthcare research ... Abbott more firmly into patient monitoring.  Kalorama said ... growing device areas, with double-digit growth expected the ... Advanced Remote Patient Monitoring . Abbott ...
(Date:4/28/2016)... 28, 2016  Marking its one year anniversary ... ovarian cancer risk test, Color Genomics ... that highly impact the most common hereditary cancers ... Color Test analyzes hereditary cancer risks for breast, ... cancers. The Color Test is physician ordered and ...
(Date:4/28/2016)... YORK , April 28, 2016  The blood ... 275 million dollars, according to Kalorama Information and The ... typing, immunoassays and nucleic acid testing.  The healthcare research ... made progress in developing blood collection stations and in ... made in Kalorama Information,s report, Blood Testing ...
Breaking Medicine Technology:
(Date:4/29/2016)... ... April 29, 2016 , ... The Gluten-Free Certification ... pleased to announce the launch of the GFCP Scoop in response ... The purpose of the GFCP Scoop site is to keep the ...
(Date:4/29/2016)... New York, NY (PRWEB) , ... April 29, 2016 , ... New York City based ... surgery . This surgery is a very effective way to treat obstructive sleep apnea. Dr. ... , Orthognathic surgery is a procedure that involves one or both jaw bones. This ...
(Date:4/29/2016)... GA (PRWEB) , ... April 29, 2016 , ... ... the closing of a growth round of funding led by Eastside Partners, with ... support the company’s rapidly growing customer base and accelerate its technology and product ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... focused entirely on patients with cancer, today announced that Lynne Malestic, RN, of ... 2016 CURE® Extraordinary Healer® for Oncology Nursing , which honors nurses who ...
(Date:4/29/2016)... ... April 29, 2016 , ... Natren, ... animal line of probiotics, Petbiotics ™, as they fondly call them. As ... rescue groups networking for their non-profit organizations. Animal rescues across the nation face ...
Breaking Medicine News(10 mins):